umap 2
Cell Morphology-Guided Small Molecule Generation with GFlowNets
Lu, Stephen Zhewen, Lu, Ziqing, Hajiramezanali, Ehsan, Biancalani, Tommaso, Bengio, Yoshua, Scalia, Gabriele, Koziarski, Michał
High-content phenotypic screening, including high-content imaging (HCI), has gained popularity in the last few years for its ability to characterize novel therapeutics without prior knowledge of the protein target. When combined with deep learning techniques to predict and represent molecular-phenotype interactions, these advancements hold the potential to significantly accelerate and enhance drug discovery applications. This work focuses on the novel task of HCI-guided molecular design. Generative models for molecule design could be guided by HCI data, for example with a supervised model that links molecules to phenotypes of interest as a reward function. However, limited labeled data, combined with the high-dimensional readouts, can make training these methods challenging and impractical. We consider an alternative approach in which we leverage an unsupervised multimodal joint embedding to define a latent similarity as a reward for GFlowNets. The proposed model learns to generate new molecules that could produce phenotypic effects similar to those of the given image target, without relying on pre-annotated phenotypic labels. We demonstrate that the proposed method generates molecules with high morphological and structural similarity to the target, increasing the likelihood of similar biological activity, as confirmed by an independent oracle model.
Supervised Training of Conditional Monge Maps
Bunne, Charlotte, Krause, Andreas, Cuturi, Marco
Optimal transport (OT) theory describes general principles to define and select, among many possible choices, the most efficient way to map a probability measure onto another. That theory has been mostly used to estimate, given a pair of source and target probability measures $(\mu, \nu)$, a parameterized map $T_\theta$ that can efficiently map $\mu$ onto $\nu$. In many applications, such as predicting cell responses to treatments, pairs of input/output data measures $(\mu, \nu)$ that define optimal transport problems do not arise in isolation but are associated with a context $c$, as for instance a treatment when comparing populations of untreated and treated cells. To account for that context in OT estimation, we introduce CondOT, a multi-task approach to estimate a family of OT maps conditioned on a context variable, using several pairs of measures $\left(\mu_i, \nu_i\right)$ tagged with a context label $c_i$. CondOT learns a global map $\mathcal{T}_\theta$ conditioned on context that is not only expected to fit all labeled pairs in the dataset $\left\{\left(c_i,\left(\mu_i, \nu_i\right)\right)\right\}$, i.e., $\mathcal{T}_\theta\left(c_i\right) \sharp \mu_i \approx \nu_i$, but should also generalize to produce meaningful maps $\mathcal{T}_\theta\left(c_{\text {new }}\right)$ when conditioned on unseen contexts $c_{\text {new }}$. Our approach harnesses and provides a novel usage for partially input convex neural networks, for which we introduce a robust and efficient initialization strategy inspired by Gaussian approximations. We demonstrate the ability of CondOT to infer the effect of an arbitrary combination of genetic or therapeutic perturbations on single cells, using only observations of the effects of said perturbations separately.
Transformers and the representation of biomedical background knowledge
Wysocki, Oskar, Zhou, Zili, O'Regan, Paul, Ferreira, Deborah, Wysocka, Magdalena, Landers, Dónal, Freitas, André
BioBERT and BioMegatron are Transformers models adapted for the biomedical domain based on publicly available biomedical corpora. As such, they have the potential to encode large-scale biological knowledge. We investigate the encoding and representation of biological knowledge in these models, and its potential utility to support inference in cancer precision medicine - namely, the interpretation of the clinical significance of genomic alterations. We compare the performance of different transformer baselines; we use probing to determine the consistency of encodings for distinct entities; and we use clustering methods to compare and contrast the internal properties of the embeddings for genes, variants, drugs and diseases. We show that these models do indeed encode biological knowledge, although some of this is lost in fine-tuning for specific tasks. Finally, we analyse how the models behave with regard to biases and imbalances in the dataset.